| Patents for C07D 321 - Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups (2,079) |
|---|
| 03/20/2012 | US8137990 Compositions for chemiluminescent detection of hydrogen peroxide |
| 03/07/2012 | EP1352650B1 Inhibitors against the production and release of inflammatory cytokines |
| 03/06/2012 | US8129355 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 02/15/2012 | CN101347508B 防己有效组分及其制备方法 Tetrandra effective ingredients and preparation methods |
| 02/14/2012 | US8114903 Cytokine modulators using cyclic glycerides of essential polyunsaturated fatty acids |
| 02/09/2012 | US20120035149 Prokineticin Receptor Antagonists And Uses Thereof |
| 01/31/2012 | US8106222 Fluorine-containing ether compound |
| 01/31/2012 | US8105746 Tertiary alcohol derivative, polymer compound and photoresist composition |
| 01/18/2012 | EP1420779B1 Process for isolating phenolic compounds |
| 01/17/2012 | US8097759 Inflammatory cytokine release inhibitor |
| 01/11/2012 | EP2403843A2 Chemiluminescent compositions, methods, assays and kits for oxidative enzymes |
| 01/04/2012 | CN1984949B Method of nucleating a polyolefin composition with acetal-based compounds |
| 01/03/2012 | CA2528656C 5ht4-antagonistic 4-(aminomethyl)-piperidine benzamides |
| 12/28/2011 | EP1748767B1 1-(3-methyl-2,4-dimethoxyphenyl)-3-(2',4'-dihydroxyphenyl)-propane as a potent tyrosinase inhibitor |
| 12/27/2011 | US8084490 Sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders |
| 12/07/2011 | EP2392561A1 Alpha-acylaminoketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 12/07/2011 | CN101142294B 用于有机电致发光器件的新颖材料 For organic electroluminescent device of novel materials |
| 12/06/2011 | US8071793 Macrolide compound |
| 12/01/2011 | US20110294882 Novel derivatives of 3,3-diphenylpropylamines |
| 11/23/2011 | CN1706847B Process for preparing 10alpha-[4'-(s,s-dioxothiomorpholin-1'-yl)]-10-deoxo-10-dihydroartemisinin |
| 11/16/2011 | CN101223177B Water-soluble arteannuin derivant, production method, medicine composition and usage |
| 11/08/2011 | US8053661 Photoelectric conversion element and imaging device |
| 10/25/2011 | US8044221 Fluorine-containing boronic acid ester compound and method for producing the same |
| 10/25/2011 | US8044217 White-emitting copolymers, representation, and use thereof |
| 10/25/2011 | US8043769 Direct methanol fuel cell |
| 10/19/2011 | CN101006072B Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders |
| 10/12/2011 | CN102210663A Diarylalkanes as potent inhibitors of binuclear enzymes |
| 09/07/2011 | CN102174440A Streptomyces antibioticu and biological preparation prepared from active product thereof and application |
| 08/18/2011 | WO2011098472A1 7 - (alk- 1 ' -enyl) - 2h-benzo [b] [1, 4] dioxepin- 3 (4h) - ones and their use in fragrance applications |
| 08/09/2011 | CA2431083C Inflammatory cytokine release inhibitor |
| 07/26/2011 | US7985772 Derivatives of 3,3-diphenylpropylamines |
| 07/21/2011 | WO2011087521A1 Chemiluminescent dyes and dye-stained particles |
| 07/21/2011 | US20110177154 Tubular nanostructure targeted to cell membrane |
| 07/20/2011 | EP2344453A2 Activators of human pyruvate kinase |
| 07/19/2011 | US7981907 Thio-substituted biarylmethanesulfinyl derivatives |
| 07/19/2011 | US7981890 Phthalazinone derivatives |
| 07/07/2011 | WO2011081080A1 Cyclic polyphenylene ether ether ketone composition and method for producing the same |
| 06/15/2011 | CN102093187A Polyketone compounds and application thereof |
| 06/02/2011 | US20110130574 Catalyst composition including zirconium compounds for esterfication reaction and method for preparing ester compounds |
| 06/01/2011 | CN102079707A Mesitylene group aromatic ketone compound, preparation method thereof and photoinitiator |
| 05/25/2011 | CN102070601A Benzodioxoheterocycloheptane liquid crystal compound and liquid crystal mixture thereof |
| 05/19/2011 | US20110118330 Hiv protease inhibitors and methods for using |
| 05/11/2011 | CN1993114B Diarylalkanes as potent inhibitors of binuclear enzymes |
| 05/10/2011 | CA2342979C Chemiluminescent 1,2-dioxetanes |
| 05/05/2011 | WO2005060456A9 Method for treating adamts-5-associate disease |
| 05/03/2011 | US7935825 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain |
| 04/20/2011 | CN101328165B Macrolides spice 1,10-dicarboxydecane propylene phthalate and production method thereof |
| 04/12/2011 | US7923446 Biaryl sulfonamides and methods for using same |
| 04/07/2011 | US20110082194 Synergistic Anticoagulant Composition |
| 04/06/2011 | EP2305690A1 Signalling compounds for use in methods of detecting hydrogen peroxide |
| 03/15/2011 | US7906659 Carbocyclic and oxacarbocyclic fumaric acid oligomers |
| 03/09/2011 | EP1928980B1 Chiral compounds |
| 03/09/2011 | CN101983964A Compound with antibacterial activity and antitumor activity and preparation method and applications thereof |
| 03/08/2011 | US7902359 Decahydronaphthalene compounds |
| 02/23/2011 | CN101981019A Process for the preparation of benzo-fused heteroaryl sulfamates and crystalline form of n-( ( (2s) -6-chloro-2,3-dihydro-l,4-benzodioxin-2-yl) methyl-sulfamide |
| 02/22/2011 | US7893152 polymer-coated pigment particles for ink jet inks; improved waterfastness, smear and smudge resistance, contrast, and discoloration inhibition |
| 02/16/2011 | CN101977903A Preparation of sulfamide derivatives |
| 02/15/2011 | US7888454 Substituted alditol compounds, compositions, and methods |
| 02/09/2011 | EP2280950A1 Process for the preparation of benzo-fused heteroaryl sulfamates and crystalline form of n- ( ( (2s) -6-chloro-2,3-dihydro-l,4-benzodioxin-2-yl) methyl-sulfamide |
| 02/09/2011 | EP1831184B1 Pyrazines and pyridines and derivatives thereof as therapeutic compounds |
| 02/02/2011 | CN101962378A Watermelon ketone synthesizing process |
| 02/01/2011 | CA2476298C Carbocyclic and oxacarbocyclic fumaric acid oligomers |
| 01/13/2011 | WO2010101839A3 Chemiluminescent compositions, methods, assays and kits for oxidative enzymes |
| 01/04/2011 | CA2220091C Nicotinic acid esters and pharmaceutical compositions containing them |
| 12/21/2010 | US7855230 FDA Orange book listed patent for fesoterodine fumarate; urinary incontinence; isobutyric acid 2-(3-diisopropylamino-1-phenylpropyl)-4-hydroxymethylphenyl ester is fesoteridine |
| 12/16/2010 | US20100316706 Carbocyclic and oxacarbocyclic fumaric acid oligomers |
| 12/08/2010 | EP1853254B1 Cytokine modulators using cyclic glycerides of essential polyunsaturated fatty acids |
| 12/02/2010 | WO2010136037A1 Novel calcium sensing receptor modulating compounds and pharmaceutical use thereof |
| 12/02/2010 | CA2762137A1 Novel calcium sensing receptor modulating compounds and pharmaceutical use thereof |
| 11/25/2010 | US20100297536 Direct Methanol Fuel Cell |
| 11/25/2010 | US20100297196 Cytokine modulators using cyclic glycerides of essential polyunsaturated fatty acids |
| 11/10/2010 | CN101066967B Synthesis process of dibenzo dioxy octanone compound |
| 11/09/2010 | US7829563 sleep disorders; (R)-2-[(S)1-(5-chloro-2-methoxy-phenyl)-3-(6-trifluoromethyl-pyridin-3-yl)-propylamino]-2-(4-fluoro-phenyl)-N-methyl-acetamide |
| 11/02/2010 | US7825265 di-aromatic compounds for treatment and prevention of diseases and disorders related to estrogen receptors; 2-fluoro-1-methoxy-4-(1-phenyl-cyclohexyl)-benzene |
| 10/28/2010 | WO2010121981A1 2h-benzo [b] [1, 4 ] dioxepin-3 (4h) -one derivative and its use as fragrance |
| 10/28/2010 | WO2010077976A3 Prokineticin receptor antagonists and uses thereof |
| 10/28/2010 | US20100274051 Inflammatory cytokine release inhibitor |
| 10/28/2010 | US20100274030 Cyclic ethers |
| 10/27/2010 | EP2242502A1 Synthesis of macrocyclic cancer chemotherapy agents and methods of use |
| 10/21/2010 | US20100267839 Diarylalkanes as potent inhibitors of binuclear enzymes |
| 10/13/2010 | EP2238122A1 Preparation of sulfamide derivatives |
| 10/07/2010 | US20100256231 Novel derivatives of 3,3-diphenylpropylamines |
| 10/06/2010 | CN101849953A Inflammatory cytokine release inhibitor |
| 10/05/2010 | US7807710 epothilone-like derivates used as anticarcinotgenic and antitumor agents |
| 09/30/2010 | US20100247475 Beta-glucuronidase inhibitor |
| 09/22/2010 | EP2230235A1 Botryosphaerones, novel depsidones and their use as medicaments |
| 09/16/2010 | US20100233279 Compositions And Methods Comprising Analogues Of Radicicol A |
| 09/10/2010 | WO2010101839A2 Chemiluminescent compositions, methods, assays and kits for oxidative enzymes |
| 09/07/2010 | US7790916 therapy of NF-kappaB mediated diseases; mitochondrial diseases; transplantation medicine |
| 08/26/2010 | US20100216970 Methods, compositions, and apparatuses for forming macrocyclic compounds |
| 08/26/2010 | US20100216870 Novel Genes Encoding a Nystatin Polyketide Synthase and Their Manipulation and Utility |
| 08/18/2010 | EP1740653B1 Method of nucleating a polyolefin composition with acetal-based compounds |
| 08/10/2010 | US7771801 Ether cyclized and acetylene functionalized [1,1']binaphthalenyl-2,2'-diol derivatives; synthesis; electrooptical, electronic, semiconducting and/or luminescent components |
| 08/10/2010 | US7771800 Liquid crystal acrylate monomers; ether cyclized and functionalized [1,1']binaphthalenyl-2,2'-diol derivatives; synthesis; electrooptical, electronic, semiconducting and/or luminescent components |
| 08/05/2010 | WO2010042867A3 Activators of human pyruvate kinase |
| 08/03/2010 | US7767661 particularly tyrosinase; preventing and treating melanin overproduction; isolated from a plant family selected from the group consisting of Compositae, Fabaceae, Lauraceae, Leguminosae, Liliaceae, Loranthaceae, Moracea, and Myristicaceae |
| 07/22/2010 | US20100184998 Organic compounds |
| 07/20/2010 | CA2486399C Calcium receptor modulating agents |
| 07/08/2010 | WO2010077976A2 Prokineticin receptor antagonists and uses thereof |
| 07/08/2010 | US20100173905 Heptacyclic compounds and the pharmaceutical uses thereof for preventing and treating diabetes and metabolic syndrome |